Lifei Cai
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Lifei Cai has a total of 10 co-authors. Here are the top co-authors by number of shared publications:
Changyuan Wang
Department of Clinical Pharmacology, College of Pharmacy, Dalian Medical University, Dalian, China
1 shared publication- Huijun Sun
Department of Clinical Pharmacology College of Pharmacy, Dalian Medical University Dalian China
1 shared publication Kexin Liu
Department of Clinical Pharmacology, College of Pharmacy, Dalian Medical University, Dalian, China
1 shared publication- Qi Liu
Department of Clinical Pharmacology, College of Pharmacy, Dalian Medical University, Dalian, China
1 shared publication Qiang Meng
Department of Clinical Pharmacology, College of Pharmacy, Dalian Medical University, Dalian, China
1 shared publication- Qining Yang
Department of Clinical Pharmacology, College of Pharmacy, Dalian Medical University, Dalian, China
1 shared publication
Latest Publications
- Open Access
- 1 January 2018
- Published by Wiley in Oxidative Medicine and Cellular Longevity
- Vol. 2018 (1) , 2876350
Activating the PGC‐1α/TERT Pathway by Catalpol Ameliorates Atherosclerosis via Modulating ROS Production, DNA Damage, and Telomere Function: Implications on Mitochondria and Telomere Link
Catalpol, an iridoid glucoside, has been found present in large quantities in the root of Rehmannia glutinosa L. and showed a strong antioxidant capacity in the previous study. In the present work, the protective effect of catalpol against AS via inhibiting oxidative stress, DNA damage, and telomere shortening was found in LDLr−/− mice. This study also shows that activation of the peroxisome proliferator‐activated receptor‐γ coactivator‐1α (PGC‐1α)/telomerase reverse transcriptase (TERT) pathway, which is the new link between mitochondria and telomere, was involved in the protective effects of catalpol. Further, by using PGC‐1α or TERT siRNA in oxLDL‐treated macrophages, it is proved that catalpol reduced oxidative stress, telomere function, and related DNA damage at least partly through activating the PGC‐1α/TERT pathway. Moreover, dual luciferase activity assay‐validated catalpol directly enhanced PGC‐1α promoter activity. In conclusion, our study revealed that the PGC‐1α/TERT pathway might be a possible therapeutic target in AS and catalpol has highly favorable characteristics for the treatment of AS via modulating this pathway.
- 1 January 2018
- Published by Wiley in Oxidative Medicine and Cellular Longevity
- Vol. 2018 (1) , 2876350
Open AccessActivating the PGC‐1α/TERT Pathway by Catalpol Ameliorates Atherosclerosis via Modulating ROS Production, DNA Damage, and Telomere Function: Implications on Mitochondria and Telomere Link
Catalpol, an iridoid glucoside, has been found present in large quantities in the root of Rehmannia glutinosa L. and showed a strong antioxidant capacity in the previous study. In the present work, the protective effect of catalpol against AS via inhibiting oxidative stress, DNA damage, and telomere shortening was found in LDLr−/− mice. This study also shows that activation of the peroxisome proliferator‐activated receptor‐γ coactivator‐1α (PGC‐1α)/telomerase reverse transcriptase (TERT) pathway, which is the new link between mitochondria and telomere, was involved in the protective effects of catalpol. Further, by using PGC‐1α or TERT siRNA in oxLDL‐treated macrophages, it is proved that catalpol reduced oxidative stress, telomere function, and related DNA damage at least partly through activating the PGC‐1α/TERT pathway. Moreover, dual luciferase activity assay‐validated catalpol directly enhanced PGC‐1α promoter activity. In conclusion, our study revealed that the PGC‐1α/TERT pathway might be a possible therapeutic target in AS and catalpol has highly favorable characteristics for the treatment of AS via modulating this pathway.